Patents matching “treatment”

US 9562237

Reduction of TGF beta signaling in myeloid cells in the treatment of cancer

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 7, 2017 · Expires Feb 2, 2037

US 9561245

Combination treatments for melanoma

The Board of Regents of the University of Texas System · Granted Feb 7, 2017 · Expires Feb 2, 2037

US 9556113

Combination uses of dichloroacetate and oxamate, and their prodrugs, for cancer treatment

SOUTH DAKOTA BOARD OF REGENTS · Granted Jan 31, 2017 · Expires Jan 26, 2037

US 9556131

Compositions, methods of use, and methods of treatment

The Regents of the University of California · Granted Jan 31, 2017 · Expires Jan 26, 2037

US 2017020867

USE OF MASITINIB FOR THE TREATMENT OF CROHN'S DISEASE

AB SCIENCE [FR] · Granted Jan 26, 2017 · Expires Jan 21, 2037

US 9549905

Treatment of inflammatory and infectious skin disorders

The Regents of the University of California · Granted Jan 24, 2017 · Expires Jan 19, 2037

US 9549913

Treatment of circadian rhythm disorders

VANDA PHARMACEUTICALS INC. · Granted Jan 24, 2017 · Expires Jan 19, 2037

US 9549943

A3 adenosine receptor ligands for use in treatment of a sexual dysfunction

CAN-FITE BIOPHARMA LTD. · Granted Jan 24, 2017 · Expires Jan 19, 2037

US 9550994

RNAI-mediated inhibition of frizzled related protein-1 for treatment of glaucoma

Arrowhead Pharmaceuticals, Inc. · Granted Jan 24, 2017 · Expires Jan 19, 2037

US 9545441

Treatment of diabetes

XBIOTECH INC. · Granted Jan 17, 2017 · Expires Jan 12, 2037

US 9545443

Methods and agents for the diagnosis and treatment of hepatocellular carcinoma

China Synthetic Rubber Corporation · Granted Jan 17, 2017 · Expires Jan 12, 2037

US 9539330

Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy

Jazz Pharmaceuticals, Inc. · Granted Jan 10, 2017 · Expires Jan 5, 2037

US 9539228

Composition containing lysine as a nutritional supplement or treatment in the case of herpes

Reiner Rittinghausen · Granted Jan 10, 2017 · Expires Jan 5, 2037

US 9540641

Cancer treatment

Ionis Pharmaceuticals, Inc. · Granted Jan 10, 2017 · Expires Jan 5, 2037

US 9539234

Treatment of circadian rhythm disorders

VANDA PHARMACEUTICALS INC. · Granted Jan 10, 2017 · Expires Jan 5, 2037

US 9534007

Methods and compositions for treatment of cyanide and hydrogen sulfide toxicity

United States of America as represented by the Secretary of the Air Force · Granted Jan 3, 2017 · Expires Dec 29, 2036

US 9527887

Treatments for gastrointestinal disorders

IRONWOOD PHARMACEUTICALS, INC. · Granted Dec 27, 2016 · Expires Dec 22, 2036

US 9526747

Use of multipotent adult stem cells in treatment of myocardial infarction and congestive heart failure

Regents of the University of Minnesota · Granted Dec 27, 2016 · Expires Dec 22, 2036

US 9526760

LEDGF peptides and formulations thereof for treatment of degenerative disorders

The Regents of the University of Colorado, a Body Corporate · Granted Dec 27, 2016 · Expires Dec 22, 2036

US 9522955

Anti-vascular endothelial growth factor receptor-2 chimeric antigen receptors and use of same for the treatment of cancer

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 20, 2016 · Expires Dec 15, 2036

US 9517240

Methods and compositions for cancer prevention and treatment

The Regents of the University of California · Granted Dec 13, 2016 · Expires Dec 8, 2036

US 9518260

Pain treatment

Benitec Biopharma Limited · Granted Dec 13, 2016 · Expires Dec 8, 2036

US 9517229

Treatment of breast cancer

The Regents of the University of Colorado, a Body Corporate · Granted Dec 13, 2016 · Expires Dec 8, 2036

US 9517222

Method for the treatment of senile dementia of the Alzheimer's type

Phenomenome Discoveries Inc. · Granted Dec 13, 2016 · Expires Dec 8, 2036